How has LeMaitre Vascular's software and technology licenses, net changed year-over-year?

LeMaitre Vascular's software and technology licenses, net decreased by 3.9% year-over-year, from $5.17M to $4.97M.

What is the long-term trend for LeMaitre Vascular's software and technology licenses, net?

Over 5 years (2020 to 2025), LeMaitre Vascular's software and technology licenses, net has grown at a 40.1% compound annual growth rate (CAGR), from $909K to $4.91M.

LeMaitre Vascular LMAT Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

ITG

Integer HoldingsITGR

——

Merit Medical SystemsMMSI

——

HaemoneticsHAE

——

Baxter InternationalBAX

——

Becton, Dickinson and CompanyBDX

——

Edwards LifesciencesEW

——

Other financials

Income statement

See full

Revenue$66.6M+11.2%

Gross profit$48.4M+16.8%

Operating income$17.8M+40.8%

Net income$15.7M+42.4%

EPS (diluted)$0.68+41.7%

Balance sheet

See full

Cash & equivalents$26.9M+6.0%

Total debt$20.9M+20.6%

Total equity$406.6M+17.0%

Total assets$629.5M+13.2%

Cash flow

See full

Operating cash flow$15.1M+67.0%

CapEx$2.8M+101%

Free cash flow$12.3M+60.8%

Valuation

See full

Market cap$2.1B+31.4%

Enterprise value$2.1B+31.6%

P/E33.7×-1.7×

P/S8.2×+1.1×

Profitability

See full

Gross margin72.4%+3.6pp

Operating margin28.5%+5.1pp

Net margin24.3%+4.4pp

FCF margin30.9%+12.7pp

Returns & leverage

See full

Return on equity16.5%+2.8pp

Debt / equity0.1×0.0×

Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LeMaitre Vascular's software and technology licenses, net?: LeMaitre Vascular (LMAT) reported software and technology licenses, net of $4.97M in Q1 2026.
How has LeMaitre Vascular's software and technology licenses, net changed year-over-year?: LeMaitre Vascular's software and technology licenses, net decreased by 3.9% year-over-year, from $5.17M to $4.97M.
What is the long-term trend for LeMaitre Vascular's software and technology licenses, net?: Over 5 years (2020 to 2025), LeMaitre Vascular's software and technology licenses, net has grown at a 40.1% compound annual growth rate (CAGR), from $909K to $4.91M.